KPF
K2 Principal Fund’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Sell |
317,126
-168,229
| -35% | -$2.94M | 0.76% | 31 |
|
|
2025
Q1 | $6.11M | Buy |
+485,355
| New | +$6.11M | 0.77% | 42 |
|
|
2024
Q4 | – | Sell |
-120,000
| Closed | -$1.74M | – | 304 |
|
|
2024
Q3 | $1.74M | Sell |
120,000
-2,341,672
| -95% | -$34M | 0.25% | 84 |
|
|
2024
Q2 | $20.9M | Buy |
2,461,672
+242,541
| +11% | +$2.06M | 3.9% | 1 |
|
|
2024
Q1 | $22.7M | Sell |
2,219,131
-835,202
| -27% | -$8.54M | 3.92% | 1 |
|
|
2023
Q4 | $16.7M | Buy |
3,054,333
+502,271
| +20% | +$2.75M | 2.13% | 3 |
|
|
2023
Q3 | $9.65M | Buy |
2,552,062
+1,280,318
| +101% | +$4.84M | 2.02% | 10 |
|
|
2023
Q2 | $8.52M | Sell |
1,271,744
-1,414,746
| -53% | -$9.48M | 1.95% | 14 |
|
|
2023
Q1 | $17.5M | Sell |
2,686,490
-185,658
| -6% | -$1.21M | 2.41% | 2 |
|
|
2022
Q4 | $24.5M | Sell |
2,872,148
-375,385
| -12% | -$3.2M | 3.72% | 2 |
|
|
2022
Q3 | $16.9M | Buy |
3,247,533
+1,705,827
| +111% | +$8.87M | 1.94% | 5 |
|
|
2022
Q2 | $6.54M | Buy |
+1,541,706
| New | +$6.54M | 0.72% | 30 |
|